ClinConnect ClinConnect Logo
Search / Trial NCT05326893

The Preventive Effects of Neurodynamic Mobilisation

Launched by UĞUR SÖZLÜ · Apr 6, 2022

Trial Information

Current as of June 07, 2025

Completed

Keywords

Delayed Onset Muscle Soreness Neurodynamic Mobilization Muscle Damage Inflammation Pain

ClinConnect Summary

The aim of this study was to investigate the effects of neurodynamic mobilization (NM) technique on muscle damage and inflammation biomarkers, and pain, pressure pain threshold, and functional status in delayed onset muscle soreness (DOMS). In the study, 34 healthy sedentary male volunteers were randomly divided into two groups as NM (n = 17) and SHAM-NM (n = 17). After the initial evaluation of the individuals, femoral nerve NM and placebo NM techniques were administered three sets a day with ten repetitions for three days a week for three weeks. Three days after the end of the application...

Gender

MALE

Eligibility criteria

  • Inclusion Criteria:
  • Being in the age range of 20-32 years.
  • Being male (Because gender difference in the magnitude of eccentric exercise-induced muscle damage might exist as shown in previous studies, only men were recruited in the present study.)
  • Being inactive according to activity guidelines published by the American College of Sports Medicine (less than 30 minutes of moderate physical activity as five times a week).
  • Exclusion Criteria:
  • Absence of DOMS symptoms,
  • History of vascular disease,
  • Recent injury or surgery to their lower extremity,
  • Neurological impairments and regular use of pain and inflammation medications.

About Uğur Sözlü

Uğur Sözlü is a dedicated clinical trial sponsor specializing in the design, management, and execution of innovative clinical research studies. With a commitment to advancing medical science, Uğur Sözlü collaborates with healthcare professionals and research institutions to facilitate the development of new therapies and interventions. The organization emphasizes rigorous ethical standards, patient safety, and data integrity throughout the research process, aiming to contribute valuable insights that enhance treatment options and improve patient outcomes across various therapeutic areas.

Locations

Ankara, Beşevler, Turkey

Patients applied

0 patients applied

Trial Officials

Selda Başar, Phd

Study Chair

Gazi University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials